JoVE Visualize What is visualize?
Stop Reading. Start Watching.
Advanced Search
Stop Reading. Start Watching.
Regular Search
Find video protocols related to scientific articles indexed in Pubmed.
Psychometric properties of the Nottwil Environmental Factors Inventory Short Form.
Arch Phys Med Rehabil
PUBLISHED: 08-21-2014
Show Abstract
Hide Abstract
To examine the psychometric properties of the Nottwil Environmental Factors Inventory Short Form (NEFI-SF) using Rasch analysis, in particular to determine its a) construct validity and b) internal consistency, and c) to develop a metric for scoring.
Related JoVE Video
Is financial hardship associated with reduced health in disability? The case of spinal cord injury in Switzerland.
PLoS ONE
PUBLISHED: 01-01-2014
Show Abstract
Hide Abstract
To investigate socioeconomic inequalities in a comprehensive set of health indicators among persons with spinal cord injury in a wealthy country, Switzerland.
Related JoVE Video
Decreasing risk of hepatitis A infection in León, Nicaragua: evidence from cross-sectional and longitudinal seroepidemiology studies.
PLoS ONE
PUBLISHED: 01-01-2014
Show Abstract
Hide Abstract
Nicaragua is highly endemic for hepatitis A. We aimed to provide an estimate of the change in the age-specific risk of hepatitis A virus (HAV) infection based on serological data from cross-sectional and longitudinal samples collected in León, Nicaragua, in 1995/96 (n = 979) and 2003 (n = 494).
Related JoVE Video
Comparison of the Utrecht Scale for Evaluation of Rehabilitation-Participation With the ICF Measure of Participation and Activities Screener and the WHO Disability Assessment Schedule II in Persons With Spinal Cord Injury.
Arch Phys Med Rehabil
PUBLISHED: 03-11-2013
Show Abstract
Hide Abstract
To validate the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-Participation) in persons with spinal cord injury (SCI) using 2 International Classification of Functioning, Disability and Health (ICF)-based instruments: the ICF Measure of Participation and Activities-Screener (IMPACT-S) and the World Health Organization Disability Assessment Schedule II (WHODAS II).
Related JoVE Video
Kinetics of maternally acquired anti-hepatitis A antibodies: prediction of waning based on maternal or cord blood antibody levels.
Vaccine
PUBLISHED: 01-02-2013
Show Abstract
Hide Abstract
Timing is critical for efficient hepatitis A vaccination in high endemic areas as high levels of maternal IgG antibodies against the hepatitis A virus (HAV) present in the first year of life may impede the vaccine response.
Related JoVE Video
Immune response increases predation risk.
Evolution
PUBLISHED: 12-08-2011
Show Abstract
Hide Abstract
Why do individuals have an imperfect immune system? Most studies suggest trade-offs associated with immunity and metabolism, and neglect ecological factors, such as predation. We provide one of the first experimental studies demonstrating a context-dependent survival cost to immune activation. In the presence of a predator, immune-challenged male field crickets showed significantly lower survival than controls, whilst there was no difference in a predator-free environment. Immune-challenged males spent more time outside their burrows and reacted slower to a simulated predator attack. We conclude that some costs of immunity are expressed via increased susceptibility to predation, indicating the importance of integrating the ecological context when investigating optimal investment in immunity.
Related JoVE Video
Measuring body structures and body functions from the International Classification of Functioning, Disability, and Health perspective: considerations for biomedical parameters in spinal cord injury research.
Am J Phys Med Rehabil
PUBLISHED: 10-07-2011
Show Abstract
Hide Abstract
The aims of this study were to provide a selection of biomedical domains based on the comprehensive International Classification of Functioning, Disability, and Health (ICF) core sets for spinal cord injury (SCI) and to present an overview of the corresponding measurement instruments.
Related JoVE Video
Design of the Swiss Spinal Cord Injury Cohort Study.
Am J Phys Med Rehabil
PUBLISHED: 10-07-2011
Show Abstract
Hide Abstract
The overall goal of the Swiss Spinal Cord Injury Cohort Study (SwiSCI) is to gain a better understanding of how to support functioning, health maintenance, and quality-of-life of persons with spinal cord injury (SCI) along the continuum of care, in the community, and along their life span. The purpose of this study was to present the SwiSCI study design. SwiSCI is composed of three complementary pathways and will include Swiss persons 16 yrs or older who have diagnoses of traumatic or nontraumatic SCI. Pathway 1 is a retrospective study of medical files of patients admitted to one of the collaborating SCI centers between 2005 and 2009. Pathway 2 is a nationwide survey of persons with chronic SCI. Pathway 3 is an inception cohort study including persons with newly acquired SCI. SwiSCI is conducted in collaboration with the Swiss Paraplegic Association and the major specialized rehabilitation centers in Switzerland. Measurement instruments that are to be used in Pathway 2 and 3 cover body structures and functions, activities, participation, life satisfaction, and personal and environmental factors. SwiSCI is a prospective cohort study that will contribute to a comprehensive understanding of the lived experience of persons with SCI.
Related JoVE Video
Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America.
PLoS Med.
PUBLISHED: 04-13-2011
Show Abstract
Hide Abstract
Although patient attrition is recognized as a threat to the long-term success of antiretroviral therapy programs worldwide, there is no universal definition for classifying patients as lost to follow-up (LTFU). We analyzed data from health facilities across Africa, Asia, and Latin America to empirically determine a standard LTFU definition.
Related JoVE Video
Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi.
BMC Infect. Dis.
PUBLISHED: 01-27-2011
Show Abstract
Hide Abstract
Loss to follow-up is a major challenge of antiretroviral treatment (ART) programs in sub-Saharan Africa. Our objective was to a) determine true outcomes of patients lost to follow-up (LTFU) and b) identify risk factors associated with successful tracing and deaths of patients LTFU from ART in a large public sector clinic in Lilongwe, Malawi.
Related JoVE Video
Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.
PLoS Med.
PUBLISHED: 01-18-2011
Show Abstract
Hide Abstract
The World Health Organization estimates that in sub-Saharan Africa about 4 million HIV-infected patients had started antiretroviral therapy (ART) by the end of 2008. Loss of patients to follow-up and care is an important problem for treatment programmes in this region. As mortality is high in these patients compared to patients remaining in care, ART programmes with high rates of loss to follow-up may substantially underestimate mortality of all patients starting ART.
Related JoVE Video
Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy.
Sex Transm Infect
PUBLISHED: 11-26-2010
Show Abstract
Hide Abstract
The Spectrum projection package uses estimates of national HIV incidence, demographic data and other assumptions to describe the consequences of the HIV epidemic in low and middle-income countries. The default parameters used in Spectrum are updated every 2 years as new evidence becomes available to inform the model. This paper reviews the default parameters that define the course of HIV progression among adults and children in Spectrum.
Related JoVE Video
Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
JAMA
PUBLISHED: 07-20-2010
Show Abstract
Hide Abstract
Long-term antiretroviral therapy (ART) use in resource-limited countries leads to increasing numbers of patients with HIV taking second-line therapy. Limited access to further therapeutic options makes essential the evaluation of second-line regimen efficacy in these settings.
Related JoVE Video
Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.
J. Acquir. Immune Defic. Syndr.
PUBLISHED: 07-01-2010
Show Abstract
Hide Abstract
Many HIV-infected children in Southern Africa have been started on antiretroviral therapy (ART), but loss to follow up (LTFU) can be substantial. We analyzed mortality in children retained in care and in all children starting ART, taking LTFU into account.
Related JoVE Video
Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi.
Trop. Med. Int. Health
PUBLISHED: 06-15-2010
Show Abstract
Hide Abstract
Malnutrition is common in HIV-infected children in Africa and an indication for antiretroviral treatment (ART). We examined anthropometric status and response to ART in children treated at a large public-sector clinic in Malawi.
Related JoVE Video
Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.
PLoS ONE
PUBLISHED: 04-08-2010
Show Abstract
Hide Abstract
Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because many patients are lost to follow-up. Outcomes in these patients are generally unknown but studies tracing patients have shown mortality to be high. We adjusted programme-level mortality in the first year of antiretroviral treatment (ART) for excess mortality in patients lost to follow-up.
Related JoVE Video
Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008.
Am J Psychiatry
PUBLISHED: 12-15-2009
Show Abstract
Hide Abstract
High rates of suicide have been described in HIV-infected patients, but it is unclear to what extent the introduction of highly active antiretroviral therapy (HAART) has affected suicide rates. The authors examined time trends and predictors of suicide in the pre-HAART (1988-1995) and HAART (1996-2008) eras in HIV-infected patients and the general population in Switzerland.
Related JoVE Video
Mortality after failure of antiretroviral therapy in sub-Saharan Africa.
Trop. Med. Int. Health
PUBLISHED: 12-09-2009
Show Abstract
Hide Abstract
To assess the outcome of patients who experienced treatment failure with antiretrovirals in sub-Saharan Africa.
Related JoVE Video
Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
AIDS
PUBLISHED: 06-18-2009
Show Abstract
Hide Abstract
In high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring is not generally available in resource-limited settings. We examined switching from nonnucleoside reverse transcriptase inhibitor (NNRTI)-based first-line regimens to protease inhibitor-based regimens in Africa, South America and Asia.
Related JoVE Video
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.
PLoS Med.
PUBLISHED: 03-13-2009
Show Abstract
Hide Abstract
Mortality in HIV-infected patients who have access to highly active antiretroviral therapy (ART) has declined in sub-Saharan Africa, but it is unclear how mortality compares to the non-HIV-infected population. We compared mortality rates observed in HIV-1-infected patients starting ART with non-HIV-related background mortality in four countries in sub-Saharan Africa.
Related JoVE Video
Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.
PLoS ONE
PUBLISHED: 02-06-2009
Show Abstract
Hide Abstract
The retention of patients in antiretroviral therapy (ART) programmes is an important issue in resource-limited settings. Loss to follow up can be substantial, but it is unclear what the outcomes are in patients who are lost to programmes.
Related JoVE Video

What is Visualize?

JoVE Visualize is a tool created to match the last 5 years of PubMed publications to methods in JoVE's video library.

How does it work?

We use abstracts found on PubMed and match them to JoVE videos to create a list of 10 to 30 related methods videos.

Video X seems to be unrelated to Abstract Y...

In developing our video relationships, we compare around 5 million PubMed articles to our library of over 4,500 methods videos. In some cases the language used in the PubMed abstracts makes matching that content to a JoVE video difficult. In other cases, there happens not to be any content in our video library that is relevant to the topic of a given abstract. In these cases, our algorithms are trying their best to display videos with relevant content, which can sometimes result in matched videos with only a slight relation.